ResMed report NPAT up 15%

Company News

by Rachael Jones

Health company, ResMed (ASX:RMD) released their results for the quarter ending 31 March 2019 showing NPAT up 15 per cent with income from operations at $157 million from last quarter's $136 million.

Revenue increased 12 per cent to $662.2 million from the same corresponding period.

This was driven by strong sales of mask and device sales in the US, Canada, Latin America and strong mask sales in Europe and Asia.

ResMed, which belongs to the Zacks Medical has quarterly earnings of $0.89 per share. This compares to earnings of $0.92 per share a year ago.

Shares in ResMed (ASX:RMD) are trading 7.64 per cent higher at $15.93.

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.